自动乳腺X线摄影乳腺密度变化可预测乳腺癌新辅助化疗后的病理缓解
本研究纳入2014年1月至2016年12月间接受新辅助化疗的357例乳腺癌患者,用自动容积乳腺密度测量法计算化疗前后容积乳腺密度百分比变化(ΔVbd%),并按ΔVbd%分为稳定组(-20%≤ΔVbd%≤20%)、降低组(ΔVbd%<-20%)和升高组(ΔVbd%>20%)。多因素分析显示,与稳定组相比,降低组获得病理完全缓解的比值比为0.420(95%CI 0.195-0.905,P=0.027),ΔVbd%分组与病理完全缓解独立相关,该趋势在Luminal B样和三阴性亚型中更明显。
要点
- ΔVbd%降低组(ΔVbd%<-20%)较稳定组病理完全缓解率更低,OR为0.420(95%CI 0.195-0.905,P=0.027)。
- ΔVbd%分组与病理完全缓解独立相关,N分期、组织学分级和乳腺癌亚型亦为独立相关因素。
- 该关联在Luminal B样和三阴性亚型中更明显。
核心结论
- ΔVbd%与新辅助化疗后病理完全缓解相关,降低组病理完全缓解率低于稳定组;自动测量ΔVbd%可能有助于预测乳腺癌新辅助化疗反应和预后。
研究设计与样本
- 研究纳入2014年1月至2016年12月间接受治疗的357例乳腺癌患者,采用自动容积乳腺密度测量法在乳腺X线摄影上计算新辅助化疗前后的容积乳腺密度。
诊断标准与关键数值
- ΔVbd%按(化疗后Vbd-化疗前Vbd)/化疗前Vbd×100%计算,稳定组为-20%≤ΔVbd%≤20%,降低组为ΔVbd%<-20%,升高组为ΔVbd%>20%;病理完全缓解定义为手术病理显示乳腺内无浸润性癌、腋窝及区域淋巴结无转移性肿瘤。
临床应用与阅片要点
- 自动测量新辅助化疗前后乳腺X线摄影的容积乳腺密度变化(ΔVbd%)可能有助于预测病理完全缓解,降低组(ΔVbd%<-20%)病理完全缓解率低于稳定组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Mammographic density is an independent risk factor for breast cancer that can change after neoadjuvant chemotherapy (NCT). This study aimed to evaluate percent changes in volumetric breast density (ΔVbd%) before and after NCT measured automatically and determine its value as a predictive marker of pathological response to NCT.
MATERIALS AND METHODS: A total of 357 patients with breast cancer treated between January 2014 and December 2016 were included. An automated volumetric breast density (Vbd) measurement method was used to calculate Vbd on mammography before and after NCT. Patients were divided into three groups according to ΔVbd%, calculated as follows: Vbd (post-NCT - pre-NCT)/pre-NCT Vbd × 100 (%). The stable, decreased, and increased groups were defined as -20% ≤ ΔVbd% ≤ 20%, ΔVbd% < -20%, and ΔVbd% > 20%, respectively. Pathological complete response (pCR) was considered to be achieved after NCT if there was no evidence of invasive carcinoma in the breast or metastatic tumors in the axillary and regional lymph nodes on surgical pathology. The association between ΔVbd% grouping and pCR was analyzed using univariable and multivariable logistic regression analyses.
RESULTS: The interval between the pre-NCT and post-NCT mammograms ranged from 79 to 250 days (median, 170 days). In the multivariable analysis, ΔVbd% grouping (odds ratio for pCR of 0.420 [95% confidence interval, 0.195-0.905; P = 0.027] for the decreased group compared with the stable group), N stage at diagnosis, histologic grade, and breast cancer subtype were significantly associated with pCR. This tendency was more evident in the luminal B-like and triple-negative subtypes.
CONCLUSION: ΔVbd% was associated with pCR in breast cancer after NCT, with the decreased group showing a lower rate of pCR than the stable group. Automated measurement of ΔVbd% may help predict the NCT response and prognosis in breast cancer.
引用
- Ahn JH, Go J, Lee SJ, et al. Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer. Korean J Radiol. 2023. PMID: 37133209. doi:10.3348/kjr.2022.0629
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。